 
1 on 1 
 
PRESS RELEASE 
 
 
 
 
 
 
 
Safe group modifies its financial agenda 
 
 
 
 
 
 
Éragny-sur-Oise, Fleurieux-sur-l'Arbresle, April 26th, 2023 at 8:30 a.m. CET - Safe (ALSAF), a company 
specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, 
particularly safe for spinal fractures treated in emergency (the "Company") announces the modiication 
of its financial agenda. 
 
François-Henri Reynaud, Chief Financial Officer of Safe Group, said: "Due to calendar constraints, we 
have decided to change the date of the Board of Directors meeting to approve the 2022 financial 
statements. Initially scheduled for April 28, 2023, it has been moved to the end of May 2023. The other 
dates remain unchanged” 
Modified Financial Agenda 2023 
Financial communication 
Date* 
Annual results 2022 
End of May 2023 (instead of  April 28th, 2023) 
Annual General Meeting 
June 30th, 2023 
First semester revenues 2023 
July 7th, 2023 
First semester results and Q3 2023 
October 10th, 2023 
Second half 2023 revenues 
January 10th, 2024 
(*) : any publication will be made after market closing. Information subject to change 
 
About Safe Group 
Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine 
pathologies, and Safe Medical (formerly LCI Medical), a medical device subcontractor for orthopaedic surgery. The group employs 
approximately 150 people. 
 
Safe Orthopaedics develops and manufactures kits combining sterile implants and single-use instruments, available at any time to the 
surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, in the 
interest of the patient and with a positive impact on hospitalization times and costs. Protected by 18 patent families, SteriSpineTM kits are CE 
marked and FDA approved. Safe Orthopaedics is headquartered in the Paris region (95610 Eragny-sur-Oise) and has subsidiaries in the United 
Kingdom, Germany, the United States, and the Lyon region (Fleurieux-sur-l'Arbresle). 
 
For more information: http://www.safeorthopaedics.com/ 
 
Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in 
France (Fleurieux-sur-l'Arbresle, 69210) and in Tunisia, offering numerous industrial services: design, industrialization, machining, finishing 
and sterile packaging. Supported by the French stimulus plan in 2020, the company invests in additive printing and will be operational in 
2022 on this new technology.  
 
For more information: http://www.safemedical.fr/ 
 
Contacts  
Safe Group 
François-Henri Reynaud  
 
  
Chief Financial and Administrative Officer   
 
Tél. : +33 (0)1 34 21 50 00 
 
 
  
investors@safeorthopaedics.com  
  
